HashiCorp (HCP)
(Delayed Data from NSDQ)
$34.04 USD
-0.03 (-0.09%)
Updated Nov 7, 2024 03:59 PM ET
After-Market: $34.05 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$34.04 USD
-0.03 (-0.09%)
Updated Nov 7, 2024 03:59 PM ET
After-Market: $34.05 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Zacks News
HCP Beats Q4 FFO Estimates, Boosts Life-Science Portfolio
by Zacks Equity Research
HCP Inc.'s (HCP) Q4 results reflect growth in same-property portfolio cash NOI. It has strengthened its Life-Science real-estate portfolio and is in process to lower Brookdale portfolio concentration.
HCP's FFO Beats Estimates in Q4, Revenues Lag Expectations
by Moumita Chattopadhyay
HCP's Q4 performance reflects growth in three-month same property portfolio cash net operating income. However, the company reported lower-than-expected revenue number for the quarter.
Why Is an Earnings Beat Unlikely for HCP (HCP) in Q4?
by Zacks Equity Research
HCP's (HCP) Q4 results are likely to benefit from rising healthcare spending and strategic investments. Nonetheless, increased supply of senior housing assets and the dilutive impact of assets sale remain concerns.
Ventas' (VTR) Q4 FFO In Line With Estimates, Revenues Beat
by Zacks Equity Research
Ventas' (VTR) Q4 results reflect improvement in same-store cash net operating income and property performance.
Taubman Centers' (TCO) Q4 FFO and Revenues Beat Estimates
by Zacks Equity Research
Taubman Centers' (TCO) Q4 results reflect lower general and administrative expenses, and higher rent per square foot. However, store closures and tenant bankruptcies continue to affect market.
Regency Centers (REG) Q3 FFO Meets Estimates, Revenues Up
by Zacks Equity Research
Regency Centers' (REG) Q4 performance reflects improvement in same-property net operating income and leasing fundamentals.
Rayonier's (RYN) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Rayonier's (RYN) Q4 results benefited from strong performance of its four timber segments. Strong liquidity position was a tailwind.
Cousins Properties' (CUZ) Q4 FFO & Revenues Beat Estimates
by Zacks Equity Research
Cousins Properties' (CUZ) Q4 results witnessed a rise in the second-generation net rent per square foot. Further, the company exited the quarter with enhanced liquidity.
Liberty (LPT) Q4 FFO & Revenues Beat Estimates, Stock Up
by Zacks Equity Research
Liberty Property's (LPT) Q4 results reflect rent escalation on renewal and replacement leases signed during the quarter in the industrial and office portfolio. Occupancy also moved up sequentially.
Highwoods (HIW) Q4 FFO Beats Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Highwood Properties' (HIW) Q4 results mirror robust growth in revenues and NOI. However, the company exited the quarter with reduced liquidity.
HCP Tops Q3 FFO, Guides Up, To Lower Brookdale Concentration
by Zacks Equity Research
HCP Inc's (HCP) Q3 performance indicates growth in three-month same-property portfolio cash net operating income. The company also announced transactions to lower Brookdale portfolio concentration.
HCP Inc (HCP) Q3 FFO and Revenues Beat Estimates
by Zacks Equity Research
HCP's Q3 performance reflects growth in three-month same property portfolio cash net operating income. Also, the company has increased its 2017 FFO as adjusted guidance range.
What's in the Offing for HCP Inc (HCP) This Earnings Season?
by Zacks Equity Research
HCP Inc's (HCP) Q3 results are likely to gain from rising healthcare spending and strategic investments. Yet, increased supply of senior housing assets and dilutive impact of assets sale remain concerns.
Alexandria (ARE) Q3 FFO & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Alexandria Real Estate Equities' (ARE) Q3 results highlight strong leasing metrics and solid growth in same-property net operating income (NOI).
AGNC Investment's (AGNC) Stock Down on Q3 Earnings Miss
by Zacks Equity Research
AGNC Investment's (AGNC) average cost of funds witnessed a sequential increase in Q3 on the back of higher repo rates. Further, the company exited the quarter with reduced liquidity.
Cousins Properties' (CUZ) Q3 FFO in Line, Revenues Beat
by Zacks Equity Research
Escalating rental revenues drove Cousin Properties' (CUZ) Q3 performance. However, a steep rise in expenses deprived the company from reporting stellar results.
Ventas' (VTR) Q3 FFO In Line With Estimates, Revenues Beat
by Zacks Equity Research
Strategic portfolio repositioning and improved rental growth enabled Ventas, Inc. (VTR) to post decent Q3 results.
Can Deleveraging Efforts Aid HCP Ride the Growth Curve?
by Zacks Equity Research
HCP poised to gain from its diverse and high-quality portfolio, rising healthcare spending and an aging population. Moreover, the company remains on track with its deleveraging plan.
HCP Beats Q2 FFO, Reaffirms View, Deleveraging on Track
by Zacks Equity Research
HCP's Q2 performance reflects growth in three-month same-property portfolio cash net operating income. The company also remains on track with its deleveraging plan.
HCP Inc. (HCP) Q2 FFO Beats Estimates, Revenues Lag
by Zacks Equity Research
HCP's Q2 performance reflects growth in three-month same property portfolio cash net operating income. Also, the company has reaffirmed full-year 2017 FFO as adjusted guidance ranges.
Taubman (TCO) Beats Q2 FFO Estimates, Revenues Decrease
by Zacks Equity Research
Taubman Centers Inc.'s (TCO) Q2 results reflect positive sales growth along with improved comparable center net operating income.
Cousins Properties (CUZ) Q2 FFO Beats Estimates, Revenues Up
by Zacks Equity Research
Cousins Properties' (CUZ) Q2 results get a boost from increased revenues.
AGNC Investment's (AGNC) Earnings Surpass Estimates in Q2
by Zacks Equity Research
AGNC Investment's (AGNC) combined annualized net interest rate spread on its balance sheet and dollar roll funded assets in Q2 gained from larger dollar roll position and favorable funding dynamics.
MAA's Q2 FFO Beats Estimates, Revenues Grow, View Updated
by Zacks Equity Research
Rise in FFO and revenues support MAA's Q2 results.
HCP to Report Q2 Earnings: What's in Store for the Stock?
by Zacks Equity Research
HCP Inc.'s (HCP) Q2 result is likely to benefit from rising healthcare spending and strategic investments. Nonetheless, increased supply of senior housing assets and dilutive impact of assets sale remain risks.